Skin collagen does clearly fall after menopause, and it tracks years since menopause more than chronological age, based on biopsy studies going back to the 1980s.

The famous '30% lost in five years' figure, however, traces back to a small 1980s cross-sectional study whose own data actually describe a decline of 1 to 2% per year, steepest early on; that specific number has never been retested in a modern, longitudinal study, so it should be treated as a rough, dated estimate rather than a precise fact. Estrogen therapy has been shown to increase skin collagen, especially in women who start with the least, and to speed wound healing, but no menopause society recommends starting hormone therapy for skin appearance alone. It's also worth knowing that most visible skin aging and all premalignant skin change is driven mainly by sun exposure, not hormones.

What to know about this answer

Both sides agree estrogen matters for skin biology. The disagreement is about magnitude and reliability of the commonly quoted numbers, since the primary datasets are small 1980s cross-sectional biopsy studies from one research group, and the iconic '30% in five years' figure has never been replicated longitudinally.

What the research shows, and which source each finding rests on

Postmenopausal women not on hormones had significantly lower skin collagen than hormone-treated women (mean difference 48%, n=55), and in untreated women collagen declined in relation to menopausal age but not chronological age.

D[1]D[2]

Type I and type III collagen were significantly lower in postmenopausal than premenopausal women and correlated inversely with years of postmenopause (r about 0.73-0.76).

D[3]

The '30% of collagen lost in five years' figure traces to a study whose own abstract states a decline of 1-2% per year across measured parameters, steepest in the early postmenopausal years; the underlying data are cross-sectional biopsies from a small 1980s clinic sample, never replicated in a modern longitudinal cohort.

D[4]

Different estrogen regimens increased skin collagen proportionally to the starting level, and percutaneous estradiol gel significantly increased abdominal skin collagen over 12 months; no menopause society recommends starting systemic hormone therapy for skin alone.

D[5]D[6]

Where the real disagreement is

Each position is shown with its own sources. A position listed here is not necessarily the accepted view.

Hormone-dominated skin change

Brincat's research series; Affinito et al.

Collagen tracks years-since-menopause rather than chronological age, and estrogen therapy measurably rebuilds collagen and accelerates wound healing, supporting a hormone-driven mechanism.

D[1]D[2]D[3]

Aging and sun exposure dominate, numbers overquoted

International Menopause Society skin review (Zouboulis et al.)

The primary datasets are small and decades old, the '30% in five years' figure has never been longitudinally replicated, and most visible skin aging along with all premalignant change is attributed primarily to environmental sun exposure rather than hormones.

D[6]

What would settle it: A longitudinal skin biopsy or validated imaging biomarker study across a staged menopause transition cohort would settle both the magnitude and the reliability of the current figures.

What is really going on here

  1. The '30% collagen' number as a supplement sales hook - is it being used to sell products it was never tested against?

Questions for your doctor

  1. Is hormone therapy ever appropriate to start for skin reasons alone, or only alongside other symptoms?
  2. How much of my skin change is likely hormonal versus sun exposure and general aging?
  3. What does the evidence actually say about oral collagen supplements for menopausal skin?
  4. What's a reasonable expectation for skin change if I do start hormone therapy for other symptoms?

Questions with no answer yet

If the '30 percent in five years' collagen figure were retested today using modern imaging methods in a properly staged, longitudinal cohort rather than the original 1980s cross-sectional biopsy samples, would the number hold up, come out higher, or come out lower?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: The underlying data are small, decades-old, cross-sectional biopsies from one research group, never replicated in a modern longitudinal cohort with staged menopause, even though the direction of the finding, collagen tracking years-since-menopause, has been independently replicated by a different, later study.

What would test it: A longitudinal skin biopsy or validated imaging biomarker study across a staged menopause transition cohort, using modern methods.

Does oral collagen supplementation actually rebuild the specific skin collagen lost after menopause, or has it simply never been tested against the estrogen-related mechanism described here?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: The chain 'menopause lowers collagen, therefore collagen powder fixes menopausal skin' has no study at either end connecting the two claims. The well-established interventional data are for estrogen therapy's effect on skin collagen, not for oral collagen supplements.

What would test it: A trial testing oral collagen supplementation, using the same biopsy or imaging methods used in the original estrogen-collagen studies, in a population defined by menopausal status.

Since estrogen therapy increases collagen most in women who start with the least, would starting hormone therapy specifically at the earliest sign of menopausal skin change, rather than years later, produce meaningfully better skin outcomes than starting later?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: Different estrogen regimens increased skin collagen proportionally to the starting level, without a study specifically testing early versus delayed initiation timing against skin collagen outcomes, and no menopause society recommends starting hormone therapy for skin alone regardless of timing.

What would test it: A trial comparing skin collagen outcomes between women starting hormone therapy near menopause onset versus several years later, among women already using hormone therapy for other indications.

Sources

  1. 1.Sex hormones and skin collagen content in postmenopausal women.Brincat M, et al. Sex hormones and skin collagen content in postmenopausal women. BMJ 1983;287(6402):1337-8 · Comparative or small study
  2. 2.Long-term effects of the menopause and sex hormones on skin thickness.Brincat M, et al. Long-term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynaecol 1985;92(3):256-9 · Comparative or small study
  3. 3.Effects of postmenopausal hypoestrogenism on skin collagen.Affinito P, et al. Effects of postmenopausal hypoestrogenism on skin collagen. Maturitas 1999;33(3):239-47 · Comparative or small study
  4. 4.A study of the decrease of skin collagen content, skin thickness, and bone mass in the postmenopausal woman.Brincat M, et al. A study of the decrease of skin collagen content, skin thickness, and bone mass in the postmenopausal woman. Obstet Gynecol 1987;70(6):840-5 · Comparative or small study
  5. 5.Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy.Brincat M, et al. Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy. Obstet Gynecol 1987;70(1):123-7 · Comparative or small study
  6. 6.Skin, hair and beyond: the impact of menopause.Zouboulis CC, et al. Skin, hair and beyond: the impact of menopause. Climacteric 2022;25(5):434-442 · Comparative or small study

The letter grades the type of study behind a claim, not the answer itself.

This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.

You are not imagining it

In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.

Start Free Mapping

Related questions

Related guides